Compliance Radar
Who was sanctioned, and for what?
Fines, court rulings and incidents from Europe and North America: 718 cases from 32 jurisdictions, each with an official source and checked against that source before publication. Filter by country, area of law and sector. Click a chart to drill down one level.
Click a bar to drill down one level.
Where?
by countryWhat for?
by area of lawAll areas of law
Who?
by company- Teva Pharmaceutical Industries (Teva-Gruppe) €462.6m 95 % · 1 case
- Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea, Transo-Pharm (C2 PHARMA Kronzeuge) €13.4m 3 % · 1 case
- Johnson & Johnson Consumer NV; Boehringer Ingelheim SComm; Haleon Belgium NV €11.2m 2 % · 1 case
- Pharnext SA €800,000 0 % · 1 case
- Tamro Eesti OÜ — 0 % · 1 case
When?
per quarter, by date of decision| Period | Cases | Total |
|---|---|---|
| Q3 2023 | 0 | — |
| Q4 2023 | 0 | — |
| Q1 2024 | 0 | — |
| Q2 2024 | 0 | — |
| Q3 2024 | 0 | — |
| Q4 2024 | 0 | — |
| Q1 2025 | 0 | — |
| Q2 2025 | 1 | €11.2m |
| Q3 2025 | 0 | — |
| Q4 2025 | 0 | — |
| Q1 2026 | 0 | — |
| Q2 2026 | 0 | — |
| Q3 2026 | 0 | — |
1 case
24 Apr 2025 Johnson & Johnson Consumer NV; Boehringer Ingelheim SComm; Haleon Belgium NVJohnson & Johnson, Boehringer, Haleon: 11.2 million EUR for shelf-placement collusion in pharmacies €11.2m
Over more than 15 years, the three OTC medicine manufacturers jointly developed the category management project ‘SMAN’, through which they steered the placement of non-prescription medicines in selected pharmacies in their favour and disadvantaged or excluded competing products. In a settlement procedure, the Autorité belge de la Concurrence / Belgische Mededingingsautoriteit (Belgian Competition Authority, BMA) imposed a total of 11,249,280.48 EUR.
Category management agreements with retailers must not push competitors off the shelf – joint planograms with competitors are off limits.
Competition law limits of category management
- Authority / court
- Autorité belge de la Concurrence / Belgische Mededingingsautoriteit (BMA)
- Area of law
- Competition law · Cartels and collusion
- Legal basis
- Code de droit économique Art. IV.1; AEUV Art. 101
- Action
- Fine
- Status of proceedings
- final
- Sector
- Chemicals and pharmaceuticals
- Employees
- 10,000 or more
- Published
- 24 Apr 2025
- BMA – Communiqué de presse N°16/2025 (24.04.2025) Press release of an authority
- BMA – Beslissing BMA-2025-RPR-13-AUD (SMAN), publieke versie Decision of an authority
Checked against the official source on 25 Sep 2026 · Direct link